Search
Barinthus Biotherapeutics PLC
BRNSAdd to Watchlist
0.740USD
-0.019-2.50%
Close 09-08 16:00（ET）
30.23MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-2.50%
5 Days
0.00%
1 Month
+18.97%
6 Months
+21.31%
Year to Date
+5.71%
1 Year
-29.52%
Key Figures
0.744Open
--High
0.00Volume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
--Turnover Ratio
0.759Prev. Close
--Low
0.00Turnover
LossP/E Static
0.55P/B
0.00%Div Yield TTM
-44.70%ROA
1.83052wk High
--Volume Ratio
-61.07MNet Profit
40.85MShares
-1.2865EPS TTM
-0.39Beta
-57.52%ROE
0.51252wk Low
--Amplitude
100.00%Gross Margin
30.23MMarket Cap
-0.85Reward/Risk
4.96%Risk Rate
More news coming soon, stay tuned...
Barinthus Biotherapeutics PLC's Score
0.10vs previous score
Forecast8.00
Financial Health6.82
Technical5.54
Valuation Dimensions8.86
Institutional Confidence3.00
Risk Assessment2.59
Media Coverage
Coverage Level
Very Low
Very High
Neutral
Analyst Rating
Barinthus Biotherapeutics PLC Technical Analysis
Technical Indicators
Buy
Summary
Buy
Moving Average
Strong buy
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.26/-0.28
Revenue / Forecast
--/--
Barinthus Biotherapeutics PLC Profile
SectorBiotechnology & Medical Research
Ticker SymbolBRNS
Number of employees105
CountryUnited Kingdom
Ownership
| Shareholders | Proportion |
|---|---|
| Oxford Science Enterprises PLC | 21.54% |
| M&G Investment Management Ltd. | 12.72% |
| Cawood (Frank Wayne) | 8.29% |
| HSG Holding Ltd. | 3.48% |
| Shareholder Types | Proportion |
|---|---|
| Venture Capital | 21.54% |
| Investment Advisor | 17.89% |
| Individual Investor | 13.12% |
| Hedge Fund | 0.85% |
Related Instruments
-1.64%
-0.01%
-0.05%
-1.88%
+1.01%
-2.99%
-1.01%
-0.85%
-3.12%
+0.90%
+0.26%
-1.77%
-1.20%
-2.00%
-1.99%
-0.26%
-0.25%
-0.74%
-1.86%
-0.35%Popular Instruments
51392.200
-97.800 (-0.19%)
30372.000
-105.900 (-0.35%)
7684.700
-22.300 (-0.29%)
14290.000
-132.000 (-0.92%)
65643.000
-486.000 (-0.73%)
6270.700
-19.300 (-0.31%)
91.123
-1.367 (-1.48%)
337.020
-2.730 (-0.80%)
225.510
-3.360 (-1.47%)
4283.850
-2.390 (-0.06%)
FAQs
What is the current price of Barinthus Biotherapeutics PLC (BRNS)?
The current price of Barinthus Biotherapeutics PLC (BRNS) is 0.74.
What is the symbol of Barinthus Biotherapeutics PLC?
The ticker symbol of Barinthus Biotherapeutics PLC is BRNS.
What is the 52-week high of Barinthus Biotherapeutics PLC?
The 52-week high of Barinthus Biotherapeutics PLC is 1.83.
What is the 52-week low of Barinthus Biotherapeutics PLC?
The 52-week low of Barinthus Biotherapeutics PLC is 0.51.
What is the market capitalization of Barinthus Biotherapeutics PLC?
The market capitalization of Barinthus Biotherapeutics PLC is 30.23M.
Is Barinthus Biotherapeutics PLC (BRNS) currently rated as Buy, Hold, or Sell?
According to analysts, Barinthus Biotherapeutics PLC (BRNS) has an overall rating of Buy, with a price target of 5.00.
What is the Earnings Per Share (EPS TTM) of Barinthus Biotherapeutics PLC (BRNS)?
The Earnings Per Share (EPS TTM) of Barinthus Biotherapeutics PLC (BRNS) is -1.29.